Shasun Pharmaceuticals Ltd Merged Half Yearly Results

Gross Sales

642.49

646.15

605.8

655.94

501.7

Excise Duty

0

0

0

0

0

Net Sales

642.49

646.15

605.8

655.94

501.7

Other Operating Income

30.38

36.8

27.88

32.6

22.44

Other Income

5.17

14.02

6.06

6.57

16.37

Total Income

678.04

696.97

639.74

695.11

540.52

Total Expenditure

604.66

609.82

597.23

613.02

498.76

PBIDT

73.38

87.15

42.51

82.09

41.75

Interest

23.91

28.59

23.94

24.63

16.87

PBDT

49.47

58.56

18.57

57.46

24.87

Depreciation

29.75

24.7

22.26

31.04

28.31

Minority Interest Before NP

0

0

0

0

0

Tax

2.81

6.31

0.02

2.95

-10.22

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

16.91

27.55

-3.71

23.47

6.76

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

16.89

28.3

-4.54

23.44

6.76

Extra-ordinary Items

0

7.85

0

0

0

Adjusted Profit After Extra-ordinary item

16.89

20.45

-4.54

23.44

6.76

EPS (Unit Curr.)

2.62

4.7

-0.77

4.14

1.2

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

13.45

12.03

12.03

11.33

11.32

Public Shareholding (Number)

4,34,80,990

3,63,80,990

3,63,80,990

3,28,61,153

3,28,61,152

Public Shareholding (%)

64.68

60.51

60.51

58.03

58.02

Pledged/Encumbered - No. of Shares

41,12,000

31,18,296

41,02,000

66,88,000

57,73,000

Pledged/Encumbered - % in Total Promoters Holding

17.32

13.13

17.28

28.14

24.29

Pledged/Encumbered - % in Total Equity

6.12

5.19

6.82

11.81

10.19

Non Encumbered - No. of Shares

1,96,30,862

2,06,24,566

1,96,40,862

1,70,74,699

1,79,89,700

Non Encumbered - % in Total Promoters Holding

82.68

86.87

82.72

71.86

75.7

Non Encumbered - % in Total Equity

29.2

34.3

32.67

30.16

31.77

PBIDTM(%)

11.42

13.48

7.01

12.51

8.32

PBDTM(%)

-

-

-

-

-

PATM(%)

2.63

4.26

-0.61

3.57

1.34